ClinicalTrials.gov
ClinicalTrials.gov Menu

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00807599
Recruitment Status : Completed
First Posted : December 12, 2008
Last Update Posted : August 2, 2018
Sponsor:
Collaborators:
Tufts Medical Center
Lahey Clinic
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2018
  Actual Study Completion Date : July 2018